CSI Market
Sign In | Register

Cytek Biosciences Inc (CTKB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CTKB Annual Balance Sheets →
Balance sheet data covering Cytek Biosciences Inc–Mar 31 2025 offers a view into how Mar 31 2026's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent65.67
Marketable Securities, Total MA196.56
Cash & Short-term Investments261.00
Accounts receivable51.90
Inventories49.79
Prepaid Expense And Other Assets Current15.38
Total Current Assets379.30
Equipment/Property/Plant Net20.47
Goodwill net16.69
Intangible Assets15.70
Long-term investments0.00
Deferred Tax Assets, Deferred Income0.00
Other Assets, Noncurrent16.95
Restricted Cash Current-
Operating Lease Right Of Use Asset10.64
Total Assets449.11
Liabilities
Accounts Payable, Trade, Current6.74
Accrued Liabilities, Current21.99
Short-term Debt0.00
Other Liabilities, Current22.17
Taxes Payable0.00
Deferred Revenue, Current DE30.03
Total Current Liabilities80.94
Long-term debt0.39
Total Long-term Debt0.39
Estimated Litigation Liability, Noncurrent LI6.64
Deferred Revenue, Noncurrent DE17.67
Other liabilities, Noncurrent15.84
Operating Lease Liability Noncurrent13.44
Total Liabilities121.47
Stockholders' Equity
Common Stock Value0.13
Additional Paid In Capital Common Stock445.75
Retained Earnings / Accumulated Deficit-120.60
Accumulated Other Comprehensive Income0.00
Other Equity2.37
Common Stockholder's Equity327.64
Total Stockholder's Equity327.64
Liabilities & Stockholder's Equity449.11
4 historic quarters locked

Sign in to unlock the full Cytek Biosciences Inc balance sheet history.

Sign In Create Free Account

About Cytek Biosciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-053496

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.